CONMED CORPORATION Accumulated Other Comprehensive Income
CONMED CORPORATION (CNMD) had Accumulated Other Comprehensive Income of -$43.37 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-29
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$43.37M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$46.30M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$49.23M.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$52.98M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$43.37M 10-Q · filed 2026-07-29 |
| 2025-12-31 | -$46.30M 10-Q · filed 2026-07-29 |
| 2025-09-30 | -$49.23M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$52.98M 10-Q · filed 2025-07-31 |
| 2025-03-31 | -$57.39M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$58.86M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$54.72M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$54.43M 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$49.80M 10-Q · filed 2024-04-25 |
| 2023-12-31 | -$50.17M 10-K · filed 2025-02-18 |
| 2023-09-30 | -$53.96M 10-Q · filed 2023-10-26 |
| 2023-06-30 | -$52.95M 10-Q · filed 2023-07-27 |
| 2023-03-31 | -$54.98M 10-Q · filed 2023-04-27 |
| 2022-12-31 | -$57.86M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$60.13M 10-Q · filed 2022-10-27 |
| 2022-06-30 | -$57.11M 10-Q · filed 2022-07-28 |
| 2022-03-31 | -$52.76M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$54.20M 10-K · filed 2023-02-21 |
| 2021-09-30 | -$59.54M 10-Q · filed 2021-10-28 |
| 2021-06-30 | -$58.34M 10-Q · filed 2021-07-29 |
| 2021-03-31 | -$62.80M 10-Q · filed 2021-04-29 |
| 2020-12-31 | -$63.68M 10-K · filed 2022-02-22 |
| 2020-09-30 | -$61.51M 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$63.64M 10-Q · filed 2020-07-30 |
| 2020-03-31 | -$66.33M 10-Q · filed 2020-04-30 |
| 2019-12-31 | -$59.28M 10-K · filed 2021-02-22 |
| 2019-09-30 | -$57.91M 10-Q · filed 2019-10-31 |
| 2019-06-30 | -$55.61M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$55.66M 10-Q · filed 2019-04-26 |
| 2018-12-31 | -$55.74M 10-K · filed 2020-02-24 |
| 2018-09-30 | -$46.43M 10-Q · filed 2018-11-02 |
| 2018-06-30 | -$47.74M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$46.33M 10-Q · filed 2018-04-26 |
| 2017-12-31 | -$49.08M 10-K · filed 2019-02-25 |
| 2017-09-30 | -$47.65M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$50.90M 10-Q · filed 2017-07-27 |
| 2017-03-31 | -$54.91M 10-Q · filed 2017-04-27 |
| 2016-12-31 | -$58.53M 10-K · filed 2018-02-26 |
| 2016-09-30 | -$51.82M 10-Q · filed 2016-10-28 |
| 2016-06-30 | -$52.38M 10-Q · filed 2016-07-28 |
| 2016-03-31 | -$50.84M 10-Q · filed 2016-05-02 |
| 2015-12-31 | -$53.89M 10-K · filed 2017-02-27 |
| 2015-09-30 | -$53.81M 10-Q · filed 2015-10-23 |
| 2015-06-30 | -$48.68M 10-Q · filed 2015-07-27 |
| 2015-03-31 | -$49.85M 10-Q · filed 2015-04-24 |
| 2014-12-31 | -$39.82M 10-K · filed 2016-02-23 |
| 2014-09-30 | -$21.42M 10-Q · filed 2014-10-24 |
| 2014-06-30 | -$15.28M 10-Q · filed 2014-07-25 |
| 2014-03-31 | -$16.62M 10-Q · filed 2014-04-25 |
| 2013-12-31 | -$17.57M 10-K · filed 2015-02-23 |
| 2013-09-30 | -$26.96M 10-Q · filed 2013-10-28 |
| 2013-06-30 | -$28.85M 10-Q · filed 2013-07-29 |
| 2013-03-31 | -$26.70M 10-Q · filed 2013-04-29 |
| 2012-12-31 | -$27.58M 10-K · filed 2014-02-24 |
| 2012-09-30 | -$27.00M 10-Q · filed 2012-10-29 |
| 2012-06-30 | -$27.88M 10-Q · filed 2012-07-30 |
| 2012-03-31 | -$25.27M 10-Q · filed 2012-05-01 |
| 2011-12-31 | -$26.35M 10-K · filed 2013-02-25 |
| 2011-09-30 | -$12.48M 10-Q · filed 2011-11-01 |
| 2011-06-30 | -$10.71M 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$15.86M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |